Lesley Clark-Loeser, MD, FAAD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Alastin/Galderma
    Topic:
    Restorative Complex
    Date added:
    02/09/2026
    Date updated:
    02/09/2026
    Relationship end date:
    12/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Acclaro
    Topic:
    UltraClear
    Date added:
    02/09/2026
    Date updated:
    02/09/2026
    Relationship end date:
    12/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    AnteAge
    Topic:
    Exosomes/Biosomes
    Date added:
    02/09/2026
    Date updated:
    02/09/2026
    Relationship end date:
    12/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Candela
    Topic:
    Devices
    Date added:
    02/09/2026
    Date updated:
    02/09/2026
    Relationship end date:
    12/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    BTL
    Topic:
    devices
    Date added:
    02/09/2026
    Date updated:
    02/09/2026
    Relationship end date:
    12/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Evolus
    Topic:
    Jeuveau
    Date added:
    02/09/2026
    Date updated:
    02/09/2026
    Relationship end date:
    12/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Neova
    Topic:
    Products
    Date added:
    02/09/2026
    Date updated:
    02/09/2026
    Relationship end date:
    12/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Prollenium
    Topic:
    Injectables
    Date added:
    02/09/2026
    Date updated:
    02/09/2026
    Relationship end date:
    12/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Revance
    Topic:
    Injectables
    Date added:
    02/09/2026
    Date updated:
    02/09/2026
    Relationship end date:
    12/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Scientis
    Topic:
    Cyspera
    Date added:
    02/09/2026
    Date updated:
    02/09/2026
    Relationship end date:
    12/31/2026

Pages

Return to 2026 Science of Skin Summit